{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:54:09Z","timestamp":1792929249205,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23056-1","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:00:59Z","timestamp":1762884059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of differentially expressed genes and associated immune cell types in South African gallbladder cancer patients"],"prefix":"10.1038","volume":"15","author":[{"given":"John","family":"Devar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Baichan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phelelani T.","family":"Mpangase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnenna","family":"Elebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey Patrick","family":"Candy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekene Emmanuel","family":"Nweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"23056_CR1","doi-asserted-by":"publisher","first-page":"110965","DOI":"10.1016\/j.ijscr.2025.110965","volume":"127","author":"CS Bowah","year":"2025","unstructured":"Bowah, C. S. et al. Management of advanced gallbladder adenocarcinoma: A case report and review of treatment strategies. Int. J. Surg. Case Rep. 127, 110965 (2025).","journal-title":"Int. J. Surg. Case Rep."},{"key":"23056_CR2","first-page":"S82","volume":"44","author":"MI Izarzugaza","year":"2016","unstructured":"Izarzugaza, M. I., Fern\u00e1ndez, L., Forman, D. & Sierra, M. S. Burden of gallbladder cancer in central and South America. Suppl. Cancer Cent. S Am. 44, S82\u2013S89 (2016).","journal-title":"Suppl. Cancer Cent. S Am."},{"key":"23056_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13023-025-03652-0","volume":"20","author":"A Afzal","year":"2025","unstructured":"Afzal, A. et al. Epidemiology of gall bladder cancer and its prevalence worldwide: a meta-analysis. Orphanet J. Rare Dis. 20, 143 (2025).","journal-title":"Orphanet J. Rare Dis."},{"key":"23056_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12014-023-09399-9","volume":"20","author":"P Baichan","year":"2023","unstructured":"Baichan, P. et al. Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry. Clin. Proteom. 20, 8 (2023).","journal-title":"Clin. Proteom."},{"key":"23056_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.surg.2021.09.016","volume":"171","author":"ZA Khan","year":"2022","unstructured":"Khan, Z. A., Khan, M. U. & Brand, M. Gallbladder cancer in africa: A higher than expected rate in a low-risk population. Surgery 171, 855\u2013858 (2022).","journal-title":"Surgery"},{"key":"23056_CR6","doi-asserted-by":"crossref","unstructured":"Schmidt, M. A., Marcano-Bonilla, L. & Roberts, L. R. Gallbladder cancer: epidemiology and genetic risk associations. Chin. Clin. Oncol. Vol 8 No 4 August 27 Clin. Oncol. Gallbladder Cancer (2019). (2019).","DOI":"10.21037\/cco.2019.08.13"},{"key":"23056_CR7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","volume":"74","author":"C Nepal","year":"2021","unstructured":"Nepal, C. et al. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes. J. Hepatol. 74, 1132\u20131144 (2021).","journal-title":"J. Hepatol."},{"key":"23056_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12885-022-09931-4","volume":"22","author":"P Samadi","year":"2022","unstructured":"Samadi, P. et al. An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer. BMC Cancer. 22, 835 (2022).","journal-title":"BMC Cancer"},{"key":"23056_CR9","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1516146\/v2","author":"S Yang","year":"2022","unstructured":"Yang, S. et al. RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation. Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-1516146\/v2 (2022).","journal-title":"Res. Sq"},{"key":"23056_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/0113862073287686240409082130","volume":"28","author":"H Yu","year":"2025","unstructured":"Yu, H. et al. Potential molecular markers for cholecystic Inflammation-Induced carcinogenesis based on RNA-Seq gene screening. Comb. Chem. High. Throughput Screen. 28, 931\u2013943 (2025).","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"23056_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3389\/fonc.2020.00823","volume":"10","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. RNA sequencing revealed signals of evolution from gallbladder stone to gallbladder carcinoma. Front. Oncol. 10, 823 (2020).","journal-title":"Front. Oncol."},{"key":"23056_CR12","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1158\/1078-0432.CCR-22-1954","volume":"28","author":"NA Giraldo","year":"2022","unstructured":"Giraldo, N. A. et al. Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention. Clin. Cancer Res. 28, 5359\u20135367 (2022).","journal-title":"Clin. Cancer Res."},{"key":"23056_CR13","doi-asserted-by":"publisher","first-page":"1356913","DOI":"10.3389\/fimmu.2024.1356913","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen, X., Sandrine, I. K., Yang, M., Tu, J. & Yuan, X. MUC1 and MUC16: critical for immune modulation in cancer therapeutics. Front. Immunol. 15, 1356913 (2024).","journal-title":"Front. Immunol."},{"key":"23056_CR14","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/annonc\/mdu006","volume":"25","author":"SG Barreto","year":"2014","unstructured":"Barreto, S. G., Dutt, A. & Chaudhary, A. A genetic model for gallbladder carcinogenesis and its dissemination. Ann. Oncol. 25, 1086\u20131097 (2014).","journal-title":"Ann. Oncol."},{"key":"23056_CR15","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1002\/cam4.5698","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med. 12, 11149\u201311165 (2023).","journal-title":"Cancer Med."},{"key":"23056_CR16","first-page":"245","volume":"1865","author":"JA Espinoza","year":"2016","unstructured":"Espinoza, J. A. et al. The inflammatory inception of gallbladder cancer. Biochim. Biophys. Acta. 1865, 245\u2013254 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"23056_CR17","doi-asserted-by":"publisher","first-page":"1354313","DOI":"10.3389\/fimmu.2024.1354313","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances. Front. Immunol. 15, 1354313 (2024).","journal-title":"Front. Immunol."},{"key":"23056_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14728222.2018.1498845","volume":"22","author":"A Aithal","year":"2018","unstructured":"Aithal, A. et al. MUC16 as a novel target for cancer therapy. Expert Opin. Ther. Targets. 22, 675\u2013686 (2018).","journal-title":"Expert Opin. Ther. Targets"},{"key":"23056_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.7150\/ijbs.52097","volume":"17","author":"Q Huo","year":"2021","unstructured":"Huo, Q. et al. Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding mesothelin to reduce DKK1 expression and activate the SGK3\/FOXO3 pathway. Int. J. Biol. Sci. 17, 574\u2013588 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"23056_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jso.20534","volume":"93","author":"A Chaube","year":"2006","unstructured":"Chaube, A., Tewari, M., Singh, U. & Shukla, H. CA 125: a potential tumor marker for gallbladder cancer. J. Surg. Oncol. 93, 665\u2013669 (2006).","journal-title":"J. Surg. Oncol."},{"key":"23056_CR21","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.4240\/wjgs.v14.i11.1272","volume":"14","author":"SR Sinha","year":"2022","unstructured":"Sinha, S. R., Prakash, P., Singh, R. K. & Sinha, D. K. Assessment of tumor markers CA 19\u2009\u2013\u20099, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer. World J. Gastrointest. Surg. 14, 1272\u20131284 (2022).","journal-title":"World J. Gastrointest. Surg."},{"key":"23056_CR22","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nrc2761","volume":"9","author":"DW Kufe","year":"2009","unstructured":"Kufe, D. W. Mucins in cancer: function, prognosis and therapy. Nat. Rev. Cancer. 9, 874\u2013885 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"23056_CR23","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/cac2.12336","volume":"42","author":"M Zhu","year":"2022","unstructured":"Zhu, M. et al. Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach. Cancer Commun. 42, 1032\u20131035 (2022).","journal-title":"Cancer Commun."},{"key":"23056_CR24","doi-asserted-by":"publisher","first-page":"54067","DOI":"10.18632\/oncotarget.10042","volume":"7","author":"MRM Hussain","year":"2016","unstructured":"Hussain, M. R. M. & Hoessli, D. C. Fang, M. N-acetylgalactosaminyltransferases in cancer. Oncotarget 7, 54067\u201354081 (2016).","journal-title":"Oncotarget"},{"key":"23056_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3892\/ol.2023.14131","volume":"26","author":"S Yu","year":"2023","unstructured":"Yu, S. et al. GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization. Oncol. Lett. 26, 543 (2023).","journal-title":"Oncol. Lett."},{"key":"23056_CR26","doi-asserted-by":"publisher","first-page":"1389713","DOI":"10.3389\/fonc.2024.1389713","volume":"14","author":"H Tian","year":"2024","unstructured":"Tian, H. et al. Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression. Front. Oncol. 14, 1389713 (2024).","journal-title":"Front. Oncol."},{"key":"23056_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/ol.2022.13217","volume":"23","author":"T Xia","year":"2022","unstructured":"Xia, T., Xiang, T. & Xie, H. Update on the role of C1GALT1 in cancer. Oncol. Lett. 23, 97 (2022).","journal-title":"Oncol. Lett."},{"key":"23056_CR28","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3389\/fonc.2019.01482","volume":"9","author":"Z Elgundi","year":"2019","unstructured":"Elgundi, Z. et al. Cancer metastasis: the role of the extracellular matrix and the Heparan sulfate proteoglycan Perlecan. Front. Oncol. 9, 1482 (2019).","journal-title":"Front. Oncol."},{"key":"23056_CR29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tibtech.2015.01.004","volume":"33","author":"R Malik","year":"2015","unstructured":"Malik, R., Lelkes, P. I. & Cukierman, E. Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer. Trends Biotechnol. 33, 230\u2013236 (2015).","journal-title":"Trends Biotechnol."},{"key":"23056_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","volume":"150","author":"R Huang","year":"2024","unstructured":"Huang, R., Kang, T. & Chen, S. The role of tumor-associated macrophages in tumor immune evasion. J. Cancer Res. Clin. Oncol. 150, 238 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"23056_CR31","doi-asserted-by":"publisher","first-page":"1325946","DOI":"10.3389\/fimmu.2024.1325946","volume":"15","author":"D Qin","year":"2024","unstructured":"Qin, D. et al. Targeting tumor-infiltrating Tregs for improved antitumor responses. Front. Immunol. 15, 1325946 (2024).","journal-title":"Front. Immunol."},{"key":"23056_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","volume":"23","author":"A Zhang","year":"2024","unstructured":"Zhang, A. et al. Regulatory T cells in immune checkpoint Blockade antitumor therapy. Mol. Cancer. 23, 251 (2024).","journal-title":"Mol. Cancer"},{"key":"23056_CR33","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/sj.bjc.6601331","volume":"89","author":"Y Nakakubo","year":"2003","unstructured":"Nakakubo, Y. et al. Clinical significance of immune cell infiltration within gallbladder cancer. Br. J. Cancer. 89, 1736\u20131742 (2003).","journal-title":"Br. J. Cancer"},{"key":"23056_CR34","first-page":"830","volume":"33","author":"PT Mpangase","year":"2021","unstructured":"Mpangase, P. T., Frost, J., Tikly, M., Ramsay, M. & Hazelhurst, S. nf-rnaSeqCount: A nextflow pipeline for obtaining Raw read counts from RNA-seq data. Afr. Comput. J. 33, 830 (2021).","journal-title":"Afr. Comput. J."},{"key":"23056_CR35","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1186\/gb-2013-14-9-r95","volume":"14","author":"F Rapaport","year":"2013","unstructured":"Rapaport, F. et al. Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data. Genome Biol. 14, R95 (2013).","journal-title":"Genome Biol."},{"key":"23056_CR36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"23056_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. EdgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"23056_CR38","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck, S., Spellman, P. T., Birney, E. & Huber, W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomart. Nat. Protoc. 4, 1184\u20131191 (2009).","journal-title":"Nat. Protoc."},{"key":"23056_CR39","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"23056_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello, F. et al. Molecular and Pharmacological modulators of the tumor immune contexture revealed by Deconvolution of RNA-seq data. Genome Med. 11, 34 (2019).","journal-title":"Genome Med."},{"key":"23056_CR41","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative Real-Time PCR experiments. Clin. Chem. 55, 611\u2013622 (2009).","journal-title":"Clin. Chem."},{"key":"23056_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods San Diego Calif. 25, 402\u2013408 (2001).","journal-title":"Methods San Diego Calif."},{"key":"23056_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2105-10-161","volume":"10","author":"W Luo","year":"2009","unstructured":"Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D. & Woolf, P. J. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinform. 10, 161 (2009).","journal-title":"BMC Bioinform."},{"key":"23056_CR44","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo, W., Brouwer, C. & Pathview An R\/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 29, 1830\u20131831 (2013).","journal-title":"Bioinformatics"},{"key":"23056_CR45","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1002\/pmic.201100066","volume":"11","author":"R Haw","year":"2011","unstructured":"Haw, R., Hermjakob, H., D\u2019Eustachio, P. & Stein, L. Reactome pathway analysis to enrich biological discovery in proteomics data sets. Proteomics 11, 3598\u20133613 (2011).","journal-title":"Proteomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23056-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:03:09Z","timestamp":1762887789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23056-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23056"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23056-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Before sample and data collection, all patients recruited for this study provided written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"39429"}}